Immunoprophylaxis failure against vertical transmission of hepatitis B virus in the Chinese population a hospital-based study and a meta-analysis

Pediatric Infectious Disease Journal

Volumn 33, Issue 9, 2014, Pages 897-903

  Lin, Xiaofang ^a   Guo, Yan ^b   Zhou, Aifen ^c   Zhang, Yu ^a   Cao, Jiangxia ^c   Yang, Mei ^a   Xiao, Fang ^c   Zhang, Bin ^c   Du, Yukai ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Centers for Disease Prevention and Control   (China)

^c Wuhan Municipal Healthcare Center for Women and Children   (China)

Author keywords

Hepatitis B virus; Immunoprophylaxis failure; Meta analysis; Vertical transmission

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INFANT; MAJOR CLINICAL STUDY; MALE; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION;

EID: 84964262556     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000315     Document Type: Article

References (70)

1. Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers. J Infect Dis. 2009;200:33-38.
2. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550-6557.
3. Shi G, Shunxiang Z. Meta-analysis on the positive rate of hepatitis B surface antigen among pregnant women in China. Chin Prev Med. 2013;14:26-30.
4. Chen LZ, Zhou WQ, Zhao SS, et al. A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population. World J Gastroenterol. 2011;17:3640-3644.
5. Lai CL, Ratziu V, Yuen M F, et al. Viral hepatitis B. Lancet. 2003;362:2089-2094.
6. Broderick AL, Jonas MM. Hepatitis B in children. Semin Liver Dis. 2003;23:59-68.
7. Ni YH, Chen DS. Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol (Paris). 2010;58:296-300.
8. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373:582-592.
9. Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat. 2011;18:369-375.
10. Wang FY, Lin P, Zhang HZ. [A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants]. Zhonghua Er Ke Za Zhi. 2008;46:61-63.
11. Zou HB, Chen Y, Duan Z P, et al. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. Plos One. 2011;6:e26748.
12. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190:489-492.
13. Su HX, Zhang YH, Zhang ZG, et al. High conservation of hepatitis B virus surface genes during maternal vertical transmission despite active and passive vaccination. Intervirology. 2011;54:122-130.
14. Boot HJ, Hahné S, Cremer J, et al. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination. J Viral Hepat. 2010;17:872-878.
15. Papaevangelou V, Paraskevis D, Anastassiadou V, et al. HBV viremia in newborns of HBsAg (+) predominantly Caucasian HBeAg (-) mothers. J Clin Virol. 2011;50:249-252.
16. Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterolog y. 2012;142:773-781. e2.
17. Song YM, Sung J, Yang S, et al. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr. 2007;166:813-818.
18. Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19:e18-e25.
19. Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18:468-473.
20. Elefsiniotis IS, Papadakis M, Vlahos G, et al. Clinical significance of hepatitis B surface antigen in cord blood of hepatitis B e-antigen-negative chronic hepatitis B virus-infected mothers. Intervirology. 2009;52:132-134.
21. Hu YL, Zhang S, Luo C et al. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. BMC Infect Dis. 2012;12:221.
22. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7:402-409.
23. Kourtis A P, Bulterys M, Hu DJ, et al. HIV-HBV coinfection-a global challenge. N Engl J Med. 2012;366:1749-1752.
24. Liu SL, Dong Y, Zhang L, et al. Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China. Arch Virol. 2009;154:437-443.
25. Bai H, Zhang L, Ma L, et al. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol. 2007;13:3625-3630.
26. Jatczak B, Gejdel E, Pajak J, et al. Study on risk factors for transplacental viral infections; effect of bacterial factors and double viral infections on virus replication in placenta and amniotic membranes. Placenta. 2001;22:360-371.
27. Wang Y, Yan YP, Zhang Y, et al. [A follow-up study on the efficacy of hepatitis B immunoglobulin combining hepatitis B vaccine in infants born to HBsAg positive mothers]. Zhonghua Liu Xing Bing Xue Za Zhi. 2007;28:550-554.
28. Lee PI, Lee CY, Huang LM, et al. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr. 1995;126(5 pt 1):716-721.
29. Wang JS, Zhu QR. A long-term follow-up of hepatitis B vaccine inoculated and HB immunoglobulin combinely immunized infants born to HBsAg positive mothers. Chin J Vaccine Immunization. 2001;7:96-99.
30. Calvo-Muñoz I, Gómez-Conesa A, Sánchez-Meca J. Prevalence of low back pain in children and adolescents: a meta-analysis. BMC Pediatr. 2013;13:14.
31. Higgins J P, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
32. Higgins J P, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
33. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
34. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046-1055.
35. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
36. Wang JS, Zhu QR. A study on the efficacy of hepatitis B immunoglobulin combining with hepatitis B vaccine in interrupting the maternal-infantile transmission of hepatitis B virus. Chin J Pract Pediatr. 2000;15:558-560.
37. Li YH, Yang LH, Zuo XL. Observations the efficacy of hepatitis B vaccine combined with hepatitis B immunoglobulin in interrupting the mother to child transmission of hepatitis B virus. Clinical Focus. 2001:555.
38. Yang YJ, Liu CC, Chen TJ, et al. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Pediatr Infect Dis J. 2003;22:584-588.
39. Zhu Q, Yu G, Yu H, et al. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J (Engl). 2003;116:685-687.
40. Wang Z, Zhang J, Yang H, et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol. 2003;71:360-366.
41. Peng J, Zhao ZH. Observation on the effect of blocking mother-to-infant transmission of hepatitis B virus with method of hepatitis B immune globulin combined with hepatitis B vaccine. West China Med J. 2005;20:336.
42. Wang JS, Chen H, Zhu QR. Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers. World J Gastroenterol. 2005;11:3582-3585.
43. Ji XH. Prevention of maternal-infant vertical transmission of HBV by combined use of intramuscular injection of HB immunoglobulin during pregnancy and HBIG and HB vaccine to infants. Shanghai J Prevent Med. 2007;19:217.
44. Zhou SF, Li GH. A study on the efficacy of intervention in perinatal to blocking mother to child transmission of hepatitis B virus. Zhejiang J Prevent Med. 2008;20:63-64.
45. Hu MX, Wang XL, Hu Y. The analysis of blocking mother to child transmission of hepatitis B virus. Chin J Birth Health Heredity. 2010;18:81-82.
46. Zhu YX, Zou HB, Chen Y, et al. Effect of different delivery modes on mother-to-infant transmission of hepatitis B virus. J Shanxi Med Univ. 2010;41:495-497.
47. Huang Y, Tong H. Clinical research of hepatitis B immunoglobulin in interrupting mother-to-infant transmission of hepatitis B virus. J Clin Pediatr. 2011;29:458-460.
48. Yi W, Li MH, Hu YH, et al. [Predictive study of HBsAg in different stages of neonatal venous blood on failure of blocking HBV mother to infant transmission]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011;25:338-341.
49. Sun X, Zhai XJ, Zhu FC, et al. Comparing the efficacy of passive-active immunoprophylaxis using different doses of hepatitis B immunoglobulin in newborns of HBsAg positive mothers. Acta Univ Med Nanjing. 2012;32:491-494.
50. Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142:773-781. e2.
51. Sun KX, Li J, Zhu FC, et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine. 2012;30:5335-5340.
52. Wang LX. The efficacy of hepatitis B immunoglobulin combining with hepatitis B vaccine in interrupting the Perinatal transmission of hepatitis B virus. Chin J Med Guide. 2012;14:365.
53. Yin Y, Wu L, Zhang J, et al. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. J Infect. 2013;66:447-452.
54. Ding Y, Sheng QJ, Ma L, et al. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J. 2013;10:17.
55. Wen WH, Chang MH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol. 2013;59:24-30.
56. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550-6557.
57. Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50:805-816.
58. Wen WH, Chen HL, Ni YH, et al. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization. Hepatology. 2011;53:429-436.
59. Söderström A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis. 2003;35:814-819.
60. Xu DZ, Yan Y P, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002;67:20-26.
61. Borgia G, Carleo MA, Gaeta GB, et al. Hepatitis B in pregnancy. World J Gastroenterol. 2012;18:4677-4683.
62. Pan CQ, Duan Z P, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012;10:452-459.
63. Amiri M J S, Roushan M R H, Baiany M, et al. Outcomes of passive-active immunoprophylaxis given to infants of mothers infected with hepatitis B virus in Babol, Iran. J Clin Virol. 2010;49:283-285.
64. Bhat P, Anderson DA. Hepatitis B virus translocates across a trophoblastic barrier. J Virol. 2007;81:7200-7207.
65. Zhu YY, Mao YZ, Wu WL, et al. Does hepatitis B virus prenatal transmission result in postnatal immunoprophylaxis failure? Clin Vaccine Immunol. 2010;17:1836-1841.
66. JM B. Laboratory diagnosis of intrauterine and perinatal virus infections. Clin Diagn Virol. 1996;5:121-129.
67. Wang Z, Liu L, Ji J, et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci. 2012;13:13308-13321.
68. Wang ZQ, Zhang S, Luo C, et al. Transplacentally acquired maternal antibody against hepatitis B surface antigen in infants and its influence on the response to hepatitis B vaccine. Plos One. 2011;6:e25130.
69. Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, et al. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine. 2009;27:6110-6115.
70. Chatzidaki V, Choumerianou D, Dimitriou H, et al. Genetic variants associated with susceptibility to mother-to-child transmission of hepatitis B virus. Eur J Gastroenterol Hepatol. 2012;24:1185-1190.